Tre recombinase: Difference between revisions
Content deleted Content added
Artoria2e5 (talk | contribs) No edit summary |
Artoria2e5 (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
'''Tre recombinase''' is an experimental [[enzyme]] that in lab tests has removed [[DNA]] inserted by [[HIV]] from infected cells.<ref name="pmid17600219">{{cite journal |first1=Indrani |last1=Sarkar |first2=Ilona |last2=Hauber |first3=Joachim |last3=Hauber |first4=Frank |last4=Buchholz |year=2007 |title=HIV-1 proviral DNA excision using an evolved recombinase |journal=[[Science (journal)|Science]] |volume=316 |issue=5833 |pages=1912–15 |pmid=17600219 |doi=10.1126/science.1141453 }}</ref> Through [[directed evolution|selective mutation]], [[Cre recombinase]] which recognizes loxP sites are modified to identify HIV [[long terminal repeats]] (loxLTR) instead. As a result, instead of performing [[Cre-Lox recombination]], the new enzyme performs recombination at HIV [[provirus]] sites.<ref>{{cite journal |url=http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1003587 |title=Highly Significant Antiviral Activity of HIV-1 LTR-Specific Tre-Recombinase in Humanized Mice |first1=Ilona |last1=Hauber |first2=Helga |last2=Hofmann-Sieber |first3=Jan |last3=Chemnitz |display-authors=3 |first4=Danilo |last4=Dubrau |journal=PLoS Pathogens |date=September 26, 2013 |doi=10.1371/journal.ppat.1003587 |pmc=3784474 }}</ref> |
'''Tre recombinase''' is an experimental [[enzyme]] that in lab tests has removed [[DNA]] inserted by [[HIV]] from infected cells.<ref name="pmid17600219">{{cite journal |first1=Indrani |last1=Sarkar |first2=Ilona |last2=Hauber |first3=Joachim |last3=Hauber |first4=Frank |last4=Buchholz |year=2007 |title=HIV-1 proviral DNA excision using an evolved recombinase |journal=[[Science (journal)|Science]] |volume=316 |issue=5833 |pages=1912–15 |pmid=17600219 |doi=10.1126/science.1141453 }}</ref> Through [[directed evolution|selective mutation]], [[Cre recombinase]] which recognizes loxP sites are modified to identify HIV [[long terminal repeats]] (loxLTR) instead. As a result, instead of performing [[Cre-Lox recombination]], the new enzyme performs recombination at HIV [[provirus]] sites.<ref>{{cite journal |url=http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1003587 |title=Highly Significant Antiviral Activity of HIV-1 LTR-Specific Tre-Recombinase in Humanized Mice |first1=Ilona |last1=Hauber |first2=Helga |last2=Hofmann-Sieber |first3=Jan |last3=Chemnitz |display-authors=3 |first4=Danilo |last4=Dubrau |journal=PLoS Pathogens |date=September 26, 2013 |doi=10.1371/journal.ppat.1003587 |pmc=3784474 }}</ref> |
||
The structure of Tre in complex with loxLTR has been resolved.<ref>{{cite journal |last1=Meinke |first1=G |last2=Karpinski |first2=J |last3=Buchholz |first3=F |last4=Bohm |first4=A |title=Crystal structure of an engineered, HIV-specific recombinase for removal of integrated proviral DNA. |journal=Nucleic acids research |date=19 September 2017 |volume=45 |issue=16 |pages=9726-9740 |doi=10.1093/nar/gkx603 |pmid=28934476 |doi-access=free}}</ref> |
The structure of Tre in complex with loxLTR has been resolved ({{PDB|5U91}}).<ref>{{cite journal |last1=Meinke |first1=G |last2=Karpinski |first2=J |last3=Buchholz |first3=F |last4=Bohm |first4=A |title=Crystal structure of an engineered, HIV-specific recombinase for removal of integrated proviral DNA. |journal=Nucleic acids research |date=19 September 2017 |volume=45 |issue=16 |pages=9726-9740 |doi=10.1093/nar/gkx603 |pmid=28934476 |doi-access=free}}</ref> |
||
==References== |
==References== |
||
Revision as of 06:11, 1 February 2020
Tre recombinase is an experimental enzyme that in lab tests has removed DNA inserted by HIV from infected cells.[1] Through selective mutation, Cre recombinase which recognizes loxP sites are modified to identify HIV long terminal repeats (loxLTR) instead. As a result, instead of performing Cre-Lox recombination, the new enzyme performs recombination at HIV provirus sites.[2]
The structure of Tre in complex with loxLTR has been resolved (PDB: 5U91).[3]
References
- ^ Sarkar, Indrani; Hauber, Ilona; Hauber, Joachim; Buchholz, Frank (2007). "HIV-1 proviral DNA excision using an evolved recombinase". Science. 316 (5833): 1912–15. doi:10.1126/science.1141453. PMID 17600219.
- ^ Hauber, Ilona; Hofmann-Sieber, Helga; Chemnitz, Jan; et al. (September 26, 2013). "Highly Significant Antiviral Activity of HIV-1 LTR-Specific Tre-Recombinase in Humanized Mice". PLoS Pathogens. doi:10.1371/journal.ppat.1003587. PMC 3784474.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - ^ Meinke, G; Karpinski, J; Buchholz, F; Bohm, A (19 September 2017). "Crystal structure of an engineered, HIV-specific recombinase for removal of integrated proviral DNA". Nucleic acids research. 45 (16): 9726–9740. doi:10.1093/nar/gkx603. PMID 28934476.
External links
- Minkel, JR (June 28, 2007). "Designer enzyme cuts HIV out of infected cells". Scientific American.
 | This genetics article is a stub. You can help Wikipedia by expanding it. |